长新冠综合征对心血管系统的影响：临床表现、机制与诊治原则

doi:10.12114/j.issn.1007-9572.2024.0058

中国全科医学 ›› 2024, Vol. 27 ›› Issue (27): 3325-3330.DOI: 10.12114/j.issn.1007-9572.2024.0058

所属专题：述评栏目最新文章合辑；心血管最新文章合辑

• 述评 • 下一篇

长新冠综合征对心血管系统的影响：临床表现、机制与诊治原则

钟旻珊, 孙伟, 孔祥清^*()

210029　江苏省南京市，南京医科大学第一附属医院心血管内科

收稿日期:2024-02-26 修回日期:2024-04-15 出版日期:2024-09-20 发布日期:2024-06-14
通讯作者: 孔祥清
钟旻珊与孙伟为共同第一作者

作者贡献：钟旻珊负责研究资料的收集整理、文章撰写；孙伟负责文章的构思设计、修订审校；孔祥清负责文章的质量控制、监督管理。
基金资助:
国家自然科学基金资助项目(82270362)

The Impact of Long COVID on Cardiovascular System: Clinical Manifestations, Mechanisms, and Principles of Diagnosis and Treatment

ZHONG Minshan, SUN Wei, KONG Xiangqing^*()

Department of Cardiology, the First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China

Received:2024-02-26 Revised:2024-04-15 Published:2024-09-20 Online:2024-06-14
Contact: KONG Xiangqing
About author:
ZHONG Minshan and SUN Wei are co-first authors

摘要/Abstract

摘要： 新型冠状病毒感染传播在全球造成了巨大的影响。在急性期感染结束后，有相当一部分感染者受到了后遗症的影响，目前暂将这一组涉及症状广泛、异质性强的临床症候群称为长新冠综合征。新型冠状病毒感染急性期相关的心血管并发症因其严重性已受到学界广泛的关注，但急性期感染结束后的心血管受累情况亟需被重视。本文就长新冠综合征心血管系统的常见临床表现、发生机制和诊治原则进行综述，意在提高人们对于长新冠综合征心血管系统并发症的认识，从而更加科学合理地应对和降低疾病带来的危害。

关键词: 新型冠状病毒感染, 长新冠综合征, 心血管疾病, 综述

Abstract:

The outbreak of COVID-19 has had a huge impact globally. After the infection, a considerable number of patients have been affected by a series of lingering symptoms or sequelae with strong heterogeneity, which we temporarily refer to as long COVID. Compared to the well-studied cardiovascular complications caused by COVID-19 during the acute phase, the cardiovascular sequelae in long COVID require greater attention. This review includes the clinical manifestations, mechanisms, and principles of diagnosis and management of cardiovascular sequelae in long COVID, aiming to improve the disease's understanding and reduce its harm scientifically.

Key words: COVID-19, Long COVID, Cardiovascular diseases, Review

中图分类号:

R 563.12

钟旻珊,孙伟,孔祥清. 长新冠综合征对心血管系统的影响：临床表现、机制与诊治原则[J]. 中国全科医学, 2024, 27(27): 3325-3330. DOI: 10.12114/j.issn.1007-9572.2024.0058.
ZHONG Minshan,SUN Wei,KONG Xiangqing. The Impact of Long COVID on Cardiovascular System: Clinical Manifestations, Mechanisms, and Principles of Diagnosis and Treatment[J]. Chinese General Practice, 2024, 27(27): 3325-3330. DOI: 10.12114/j.issn.1007-9572.2024.0058.

参考文献 54

[1]	World Health Organization. WHO COVID-19 dashboard[EB/OL]. （2024-02-04）[2024-02-18].
[2]	World Health Organization Europe. Post COVID-19 condition （Long COVID）[EB/OL]. （2022-12-07）[2024-02-18].
[3]	CDC. Post-COVID Conditions[EB/OL]//U.S. Centers for Disease Control and Prevention. （2023-07-20）[2024-02-18].
[4]	The U.S. Department of Health and Human Services. LONG COVID TERMS&DEFINITIONS[EB/OL]//LONG COVID TERMS&DEFINITIONS. （2024-03-26）[2024-04-11].
[5]	National Institute for Health and Care Excellence，Royal College of General Practitioners，Scottish Intercollegiate Guidelines Network. COVID-19 rapid guideline：managing the long-term effects of COVID-19[Z/OL]. （2024-01-25）[2024-02-18].
[6]	U.S. Department of Health and Human Services，Office of the Assistant Secretary for Health. National Research Action Plan on Long COVID[A/OL]. [2024-02-18].
[7]	栾涛，杨罡，王帅颖，等. "长新冠"综合征研究最新进展[J]. 实用医学杂志，2023，39（10）：1195-1200. DOI：10.3969/j.issn.1006-5725.2023.10.001.
[8]	GUO T，FAN Y Z，CHEN M，et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 （COVID-19）[J]. JAMA Cardiol，2020，5（7）：811-818. DOI：10.1001/jamacardio.2020.1017.
[9]	COMMITTEE W，GLUCKMAN T J，BHAVE N M，et al. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults：myocarditis and other myocardial involvement，post-acute sequelae of SARS-CoV-2 infection，and return to play：a report of the American college of cardiology solution set oversight committee[J]. J Am Coll Cardiol，2022，79（17）：1717-1756. DOI：10.1016/j.jacc.2022.02.003.
[10]	DAVIS H，ASSAF G，MCCORKELL L，et al. Characterizing Long COVID in an International Cohort：7 Months of Symptoms and Their Impact （preprint）[J/OL]. [2024-02-18].
[11]	HUANG L X，YAO Q，GU X Y，et al. 1-year outcomes in hospital survivors with COVID-19：a longitudinal cohort study[J]. Lancet，2021，398（10302）：747-758. DOI：10.1016/S0140-6736(21)01755-4.
[12]	HUANG L，ZHAO P J，TANG D Z，et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging[J]. JACC Cardiovasc Imaging，2020，13（11）：2330-2339. DOI：10.1016/j.jcmg.2020.05.004.
[13]	PUNTMANN V O，CARERJ M L，WIETERS I，et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 （COVID-19）[J]. JAMA Cardiol，2020，5（11）：1265-1273. DOI：10.1001/jamacardio.2020.3557.
[14]	LAI Y J，LIU S H，MANACHEVAKUL S，et al. Biomarkers in long COVID-19：a systematic review[J]. Front Med，2023，10：1085988. DOI：10.3389/fmed.2023.1085988.
[15]	GRÜN S，SCHUMM J，GREULICH S，et al. Long-term follow-up of biopsy-proven viral myocarditis[J]. JACC，2012，59（18）：1604-1615. DOI：10.1016/j.jacc.2012.01.007.
[16]	GULATI A，JABBOUR A，ISMAIL T F，et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy[J]. JAMA，2013，309（9）：896-908. DOI：10.1001/jama.2013.1363.
[17]	PUNTMANN V O，CARR-WHITE G，JABBOUR A，et al. T1-mapping and outcome in nonischemic cardiomyopathy：all-cause mortality and heart failure[J]. JACC Cardiovasc Imaging，2016，9（1）：40-50. DOI：10.1016/j.jcmg.2015.12.001.
[18]	PUNTMANN V O，CARR-WHITE G，JABBOUR A，et al. Native T1 and ECV of noninfarcted myocardium and outcome in patients with coronary artery disease[J]. J Am Coll Cardiol，2018，71（7）：766-778. DOI：10.1016/j.jacc.2017.12.020.
[19]	VISCO V，VITALE C，RISPOLI A，et al. Post-COVID-19 syndrome：involvement and interactions between respiratory，cardiovascular and nervous systems[J]. J Clin Med，2022，11（3）：524. DOI：10.3390/jcm11030524.
[20]	DAVIS H E，MCCORKELL L，VOGEL J M，et al. Long COVID：major findings，mechanisms and recommendations[J]. Nat Rev Microbiol，2023，21（3）：133-146. DOI：10.1038/s41579-022-00846-2.
[21]	SANTORO F，NÚÑEZ-GIL I J，VIANA-LLAMAS M C，et al. Risk prediction of major cardiac adverse events and all-cause death following covid-19 hospitalization at one year follow-up：the HOPE-2 score[J]. Eur J Intern Med，2024：S0953-S6205（24）00096-7. DOI：10.1016/j.ejim.2024.03.002.
[22]	LAM I C H，ZHANG R，MAN K K C，et al. Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection[J]. Nat Commun，2024，15（1）：1716. DOI：10.1038/s41467-024-45953-1.
[23]	TSAMPASIAN V，BÄCK M，BERNARDI M，et al. Cardiovascular disease as part of Long COVID：a systematic review[J]. Eur J Prev Cardiol，2024：zwae070. DOI：10.1093/eurjpc/zwae070.
[24]	BLOMBERG B，MOHN K G I，BROKSTAD K A，et al. Long COVID in a prospective cohort of home-isolated patients[J]. Nat Med，2021，27（9）：1607-1613. DOI：10.1038/s41591-021-01433-3.
[25]	MUNBLIT D，BOBKOVA P，SPIRIDONOVA E，et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19[J]. Clin Exp Allergy，2021，51（9）：1107-1120. DOI：10.1111/cea.13997.
[26]	OGUNGBE O，GILOTRA N A，DAVIDSON P M，et al. Cardiac postacute sequelae symptoms of SARS-CoV-2 in community-dwelling adults：cross-sectional study[J]. Open Heart，2022，9（2）：e002084. DOI：10.1136/openhrt-2022-002084.
[27]	GARG M，MARALAKUNTE M，GARG S，et al. The conundrum of long-COVID-19：a narrative review[J]. Int J Gen Med，2021，14：2491-2506. DOI：10.2147/IJGM.S316708.
[28]	LINDNER D，FITZEK A，BRÄUNINGER H，et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases[J]. JAMA Cardiol，2020，5（11）：1281-1285. DOI：10.1001/jamacardio.2020.3551.
[29]	SWANK Z，SENUSSI Y，MANICKAS-HILL Z，et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae[J]. Clin Infect Dis，2023，76（3）：e487-490. DOI：10.1093/cid/ciac722.
[30]	LONG Q X，TANG X J，SHI Q L，et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections[J]. Nat Med，2020，26（8）：1200-1204. DOI：10.1038/s41591-020-0965-6.
[31]	LARSEN N W，STILES L E，SHAIK R，et al. Characterization of autonomic symptom burden in long COVID：a global survey of 2 314 adults[J]. Front Neurol，2022，13：1012668. DOI：10.3389/fneur.2022.1012668.
[32]	GARLAND E M，GAMBOA A，NWAZUE V C，et al. Effect of high dietary sodium intake in patients with postural tachycardia syndrome[J]. J Am Coll Cardiol，2021，77（17）：2174-2184. DOI：10.1016/j.jacc.2021.03.005.
[33]	RAJ S R，BOURNE K M，STILES L E，et al. Postural orthostatic tachycardia syndrome（POTS）：priorities for POTS care and research from a 2019 National Institutes of Health Expert Consensus Meeting - Part 2[J]. Auton Neurosci，2021，235：102836. DOI：10.1016/j.autneu.2021.102836.
[34]	EL-MEDANY A，ADAMS Z H，BLYTHE H C，et al. Carotid body dysregulation contributes to Long COVID symptoms[J]. Commun Med，2024，4（1）：20. DOI：10.1038/s43856-024-00447-5.
[35]	LATARO R M，MORAES D J A，GAVA F N，et al. P2X3 receptor antagonism attenuates the progression of heart failure[J]. Nat Commun，2023，14（1）：1725. DOI：10.1038/s41467-023-37077-9.
[36]	LIBBY P，LÜSCHER T. COVID-19 is，in the end，an endothelial disease[J]. Eur Heart J，2020，41（32）：3038-3044. DOI：10.1093/eurheartj/ehaa623.
[37]	宋时旭，郑雅莉，高占成. 长新冠综合征概述[J]. 中国实用内科杂志，2023，43（9）：705-708. DOI：10.19538/j.nk2023090101.
[38]	SCHULTHEIß C，WILLSCHER E，PASCHOLD L，et al. From online data collection to identification of disease mechanisms：the IL-1ß，IL-6 and TNF-α cytokine triad is associated with post-acute sequelae of COVID-19 in a digital research cohort[J]. SSRN Journal，2021. DOI：10.2139/ssrn.3963839.
[39]	SOLLINI M，CICCARELLI M，CECCONI M，et al. Vasculitis changes in COVID-19 survivors with persistent symptoms：an[18F]FDG-PET/CT study[J]. Eur J Nucl Med Mol Imaging，2021，48（5）：1460-1466. DOI：10.1007/s00259-020-05084-3.
[40]	WALLUKAT G，HOHBERGER B，WENZEL K，et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms[J]. J Transl Autoimmun，2021，4：100100. DOI：10.1016/j.jtauto.2021.100100.
[41]	KLEIN J，WOOD J，JAYCOX J R，et al. Distinguishing features of long COVID identified through immune profiling[J]. Nature，2023，623（7985）：139-148. DOI：10.1038/s41586-023-06651-y.
[42]	RAVEENDRAN A V. Long COVID-19：challenges in the diagnosis and proposed diagnostic criteria[J]. Diabetes Metab Syndr，2021，15（1）：145-146. DOI：10.1016/j.dsx.2020.12.025.
[43]	FAGHY M A，TATLER A，CHIDLEY C，et al. The physiologic benefits of optimizing cardiorespiratory fitness and physical activity - From the cell to systems level in a post-pandemic world[J]. Prog Cardiovasc Dis，2024：S0033-0620(24)00028-8. DOI：10.1016/j.pcad.2024.02.006.
[44]	NICE cautions against using graded exercise therapy for patients recovering from covid-19[J]. BMJ，2020，370：m2933. DOI：10.1136/bmj.m2933.
[45]	FAGHY M A，DUNCAN R，HUME E，et al. Developing effective strategies to optimize physical activity and cardiorespiratory fitness in the long Covid population- The need for caution and objective assessment[J]. Prog Cardiovasc Dis，2024：S0033-0620(24)00039-2. DOI：10.1016/j.pcad.2024.03.003.
[46]	BATEMAN L，BESTED A C，BONILLA H F，et al. Myalgic encephalomyelitis/chronic fatigue syndrome：essentials of diagnosis and management[J]. Mayo Clin Proc，2021，96（11）：2861-2878. DOI：10.1016/j.mayocp.2021.07.004.
[47]	FU Q，VANGUNDY T B，SHIBATA S，et al. Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome[J]. Hypertension，2011，58（2）：167-175. DOI：10.1161/HYPERTENSIONAHA.111.172262.
[48]	RENTSCH C T，BECKMAN J A，TOMLINSON L，et al. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States：cohort study[J]. BMJ，2021，372：n311. DOI：10.1136/bmj.n311.
[49]	WANG C，YU C，JING H，et al. Long COVID：The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation[J/OL]. [2024-02-22].
[50]	MEIZLISH M L，GOSHUA G，LIU Y W，et al. Intermediate-dose anticoagulation，aspirin，and in-hospital mortality in COVID-19：a propensity score-matched analysis[J]. Am J Hematol，2021，96（4）：471-479. DOI：10.1002/ajh.26102.
[51]	SANTORO F，NUÑEZ-GIL I J，VITALE E，et al. Antiplatelet therapy and outcome in COVID-19：the Health Outcome Predictive Evaluation Registry[J]. Heart，2022，108（2）：130-136. DOI：10.1136/heartjnl-2021-319552.
[52]	LERMAN A，BURNETT J C Jr，HIGANO S T，et al. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans[J]. Circulation，1998，97（21）：2123-2128. DOI：10.1161/01.cir.97.21.2123.
[53]	The U.S. Department of Health Human Services Office for Civil Rights. Guidance on＂Long COVID＂as a Disability Under the ADA，Section 504，and Section 1557[EB/OL]. （2021-01-26）[2024-02-18].
[54]	World Health Organization Emergency Preparedness （WPE），WHO Headquarters （HQ）. From emergency response to long-term COVID-19 disease management：sustaining gains made during the COVID-19 pandemic（Strategic Preparedness and Response plan for 2023-2025）[Z/OL]. （2023-05-03）[2024-02-22].

长新冠综合征对心血管系统的影响：临床表现、机制与诊治原则

The Impact of Long COVID on Cardiovascular System: Clinical Manifestations, Mechanisms, and Principles of Diagnosis and Treatment

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 54

相关文章 15

编辑推荐

Metrics

留言

[1]	李静, 刘子琦, 钱莉, 姚瑞芹. 微生物-肠-脑轴在癫痫中的作用研究进展[J]. 中国全科医学, 2026, 29(32): 4821-4826.
[2]	易珊烨, 杨荣, 廖晓阳, 周伊恒, 刘力滴, 杨梓钰, 白佳欣, 贾禹, 张欣. 2024年《动脉压力、结构及功能评估》专家共识解读[J]. 中国全科医学, 2026, 29(32): 4690-4694.
[3]	王诗怡, 范小静, 司亚飞, 周忠良. 健康老龄化背景下老年人内在能力关键测量技术的研究进展[J]. 中国全科医学, 2026, 29(31): 4662-4666.
[4]	贺洋, 杨荣, 沈灿, 易珊烨, 刘力滴, 赵茜, 万智, 廖晓阳. 衰弱轨迹及其影响因素研究进展[J]. 中国全科医学, 2026, 29(30): 4372-4378.
[5]	赵家义, 樊剑, 于德华. 1秒率正常的肺功能受损人群现状、挑战及应对策略[J]. 中国全科医学, 2026, 29(30): 4366-4371.
[6]	李喜玲, 张帆, 杨欣月, 杨姮. "零食式锻炼"在慢性病管理中应用的范围综述[J]. 中国全科医学, 2026, 29(30): 4472-4479.
[7]	陈毓婧, 王岩, 李光, 董本超, 杨培川, 马剑雄. 数字技术在亚洲地区老年人肌少症干预中应用的范围综述[J]. 中国全科医学, 2026, 29(29): 4200-4210.
[8]	蒋晨, 安妮, 徐运璟, 牛少娜, 李凤鸣, 姜良美. 心血管-肾脏-代谢综合征患者住院特征及医疗资源消耗的横断面研究[J]. 中国全科医学, 2026, 29(28): 4172-4178.
[9]	卢鸿润, 张睿, 赵钰, 李佳禛, 王为强. 心血管代谢性共病与估算肾小球滤过率的关联性研究[J]. 中国全科医学, 2026, 29(28): 4179-4186.
[10]	解霄芸, 刘晨曦, 柳羽姝, 周艺涵. 中国基层医疗卫生机构人工智能研究实践及潜在数据贫困问题：一项范围综述[J]. 中国全科医学, 2026, 29(28): 4067-4077.
[11]	冯雅晨, 刘乐伟, 薛金月, 孙先林, 刘寰忠. 可穿戴技术在精神障碍诊疗中的研究进展[J]. 中国全科医学, 2026, 29(27): 4016-4025.
[12]	郭俊池, 张明妍, 秦广宁, 徐强, 路美娟. 新型指标TANS01在痰湿体质人群心血管风险评估中的初步应用研究[J]. 中国全科医学, 2026, 29(27): 3924-3930.
[13]	赵原原, 刘普林, 代娟, 张刚, 张微, 张晓霞, 邓青, 严亚琼. 中国内脏脂肪指数与老年人全因死亡及死因别死亡风险的关联研究[J]. 中国全科医学, 2026, 29(26): 3781-3787.
[14]	杨芮, 廖晓阳, 黄传应, 杨梓钰, 沈灿, 贾禹, 刘力滴, 杨荣. 2024英国和爱尔兰高血压协会立场声明：青年高血压的调查与管理解读[J]. 中国全科医学, 2026, 29(26): 3726-3732.
[15]	刘雅慧, 徐雅楠, 袁玲, 武丽桂, 周玉洁, 康玉彪. 基于优先级决策的安宁疗护患者分诊研究范围综述[J]. 中国全科医学, 2026, 29(24): 3538-3544.